Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome

INTRODUCTION: We investigated whether mRNA levels of E2F1, a key transcription factor involved in proliferation, differentiation and apoptosis, could be used as a surrogate marker for the determination of breast cancer outcome. METHODS: E2F1 and other proliferation markers were measured by quantitat...

Descripción completa

Detalles Bibliográficos
Autores principales: Vuaroqueaux, Vincent, Urban, Patrick, Labuhn, Martin, Delorenzi, Mauro, Wirapati, Pratyaksha, Benz, Christopher C, Flury, Renata, Dieterich, Holger, Spyratos, Frédérique, Eppenberger, Urs, Eppenberger-Castori, Serenella
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1929097/
https://www.ncbi.nlm.nih.gov/pubmed/17535433
http://dx.doi.org/10.1186/bcr1681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1929097/
https://www.ncbi.nlm.nih.gov/pubmed/17535433
http://dx.doi.org/10.1186/bcr1681

Ejemplares similares